Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2014

Dec 10, 2014

35380_dirs_2014-12-10_e80b3e67-a244-49f5-af27-9a56b0c9384b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2014-12-08

Reporting Person: Sullivan Michael O'Keefe (CFO, Secretary and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-08 Employee Stock Option (Right to Buy) $0.88 A 40000 Acquired 2024-12-08 Common Stock (40000) Direct

Footnotes

F1: Issuance of stock options to Mr. Sullivan in connection with service to the Company pursuant to the 2012 Equity Incentive Plan. These shares vest as follows: 20,000 on the first anniversary of the date of the grant (December 8, 2015) with the additional 20,000 vesting on the second anniversary of the date of the grant (December 8, 2016). The option exercise was the closing price on the date of the grant, December 8, 2014.